 REDWOOD CITY, Calif., Jan. 22, 2021 GLOBE NEWSWIRE -- Coherus BioSciences, Inc. Coherus or the Company, Nasdaq: CHRS, today announced that effective January 21, 2021, the compensation committee of the Companys board of directors granted options to purchase an aggregate of 60,000 shares of the common stock of the Company to 3 newly hired non-officer employees, with a per share exercise price of 17.99, the closing trading price on the grant date. 